Abstract

A clinical decision report appraising Barchel D, Stolar O, De-Haan T, et al. Oral cannabidiol use in children with autism spectrum disorder to treat related symptoms and co-morbidities. Frontiers in Pharmacology. 2019;9. https://doi.org/10.3389/fphar.2018.01521

Highlights

  • Hunter Walker is a 9-year old boy presenting to the neurology clinic for follow-up for controlled focal motor seizures, developmental delay, cerebral palsy, and autism spectrum disorder (ASD) with severe behavioral symptoms

  • Barchel D, Stolar O, De-Haan T, et al Oral cannabidiol use in children with autism spectrum disorder to treat related symptoms and co-morbidities

  • Little is known about cannabidiol for improving severe behavioral symptoms of autistic spectrum disorder

Read more

Summary

Clinical Context

Hunter Walker (pseudonym) is a 9-year old boy presenting to the neurology clinic for follow-up for controlled focal motor seizures, developmental delay, cerebral palsy, and autism spectrum disorder (ASD) with severe behavioral symptoms. His current medication regime includes clobazam and lacosamide. His mother is having a lot of trouble managing his behavior at home. Ms Walker does have a friend who has been successful in managing her son’s ASD behavioral outbursts with cannabidiol oil. Ms Walker was hesitant to add another medication and insists on trying something more “natural.” She comes to us for our professional opinion on cannabidiol oil use in ASD

Research Article
Related Literature
Critical Appraisal
Clinical Application
Findings
New Knowledge Related to Clinical Decision Science
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call